Author details

Full Name

Fabien Calvo

Affiliation

Universite de Paris-Cite

ORCID

Career Start Year

1979

Papers

221

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37377900	Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas.	Cancer Res Commun	2023
35338446	Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications.	Diabetes Ther	2022
35503718	Ageing and cancer: a research gap to fill.	Mol Oncol	2022
32272210	JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.	Ann Oncol	2020
33564664	Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.	Biomed Hub	2020
32775335	Propelling Health Care into the Twenties.	Biomed Hub	2020
32749074	Towards a cancer mission in Horizon Europe: recommendations.	Mol Oncol	2020
30657633	Cancer Core Europe: A translational research infrastructure for a European mission on cancer.	Mol Oncol	2019
31670486	Towards a Cancer Mission in Horizon Europe.	Mol Oncol	2019
30241002	Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st century.	Eur J Cancer	2018
28538124	Sharing Clinical and Genomic Data on Cancer - The Need for Global Solutions.	N Engl J Med	2017
28453708	Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape.	Ann Oncol	2017
28649644	Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.	NPJ Breast Cancer	2017
27081717	Wild-type AAV Insertions in Hepatocellular Carcinoma Do Not Inform Debate Over Genotoxicity Risk of Vectorized AAV.	Mol Ther	2016
27406316	A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers.	Nat Commun	2016
26935016	AAV2 and Hepatocellular Carcinoma.	Hum Gene Ther	2016
25822088	Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.	Nat Genet	2015
26301494	Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.	Nat Genet	2015
26526696	All the World's a Stage: Facilitating Discovery Science and Improved Cancer Care through the Global Alliance for Genomics and Health.	Cancer Discov	2015
26337344	Hyperglycaemia per se does not affect erythrocyte glucose-6-phosphate dehydrogenase activity in ketosis-prone diabetes.	Diabetes Metab	2015
25825981	EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF.	Oncotarget	2015
24127186	Prodomain of the proprotein convertase subtilisin/kexin Furin (ppFurin) protects from tumor progression and metastasis.	Carcinogenesis	2014
25344860	A novel tumor suppressor function of Kindlin-3 in solid cancer.	Oncotarget	2014
24735922	Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.	Cancer Cell	2014
24961901	Repression of liver colorectal metastasis by the serpin Spn4A a naturally occurring inhibitor of the constitutive secretory proprotein convertases.	Oncotarget	2014
22933436	Î²- and Î±-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission.	Diabetes Care	2013
24123600	High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients.	Oncotarget	2013
23714540	Europe does it better: molecular testing across a national health care system-the French example.	Am Soc Clin Oncol Educ Book	2013
22422408	Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groups.	Clin Cancer Res	2012
22777058	Tumour molecular profiling for deciding therapy-the French initiative.	Nat Rev Clin Oncol	2012
22443116	EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.	BMC Cancer	2012
22561517	Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.	Nat Genet	2012
20627876	Inclusion of patients with acute leukemia in clinical trials: a prospective multicenter survey of 1066 cases.	Ann Oncol	2011
21805244	Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cells.	Methods Mol Biol	2011
20404912	Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes.	PLoS One	2010
20824203	EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.	PLoS One	2010
20544684	Identification of a novel biomarker signature associated with risk for bone metastasis in patients with renal cell carcinoma.	Int J Biol Markers	2010
20502715	Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.	PLoS One	2010
20439456	Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.	Clin Cancer Res	2010
20625388	Zebrafish ProVEGF-C expression, proteolytic processing and inhibitory effect of unprocessed ProVEGF-C during fin regeneration.	PLoS One	2010
20563721	Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors.	Cancer Immunol Immunother	2010
20651357	Antisense inhibition of amphiregulin expression reduces EGFR phosphorylation in transformed human breast epithelial cells.	Anticancer Res	2010
20216240	Complete regression of a previously untreated melanoma brain metastasis with ipilimumab.	Melanoma Res	2010
20144232	Distinct expression patterns of the E3 ligase SIAH-1 and its partner Kid/KIF22 in normal tissues and in the breast tumoral processes.	J Exp Clin Cancer Res	2010
19043416	Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness.	Nat Genet	2009
19858763	Interest in an original methodology to define the optimal dosage of interferon-alpha-2a in metastatic melanoma patients.	Melanoma Res	2009
19837976	EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2alpha-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2.	Blood	2009
19720905	Improving cancer outcomes through international collaboration in academic cancer treatment trials.	J Clin Oncol	2009
19404919	Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.	Int J Biol Markers	2009
19361401	[Colorectal cancer].	Med Sci (Paris)	2009

1 - 50 of 221

David J Liewehr

Center for Cancer Research

Career Start Year 1999

Number of shared co-authors 0

Paul N Span

Radboud University Medical Center

Career Start Year 1993

Number of shared co-authors 5

Bhaskar Kallakury

Georgetown University

Career Start Year 1993

Number of shared co-authors 0

Mai Nguyen

University of California Riverside

Career Start Year 1992

Number of shared co-authors 0

Roger Chammas

Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo

Career Start Year 1989

Number of shared co-authors 2

Luc Dirix

GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp

Career Start Year 1988

Number of shared co-authors 6

Jose A Lopez-Martin

Hospital Universitario 12 de Octubre

Career Start Year 1988

Number of shared co-authors 1

Susan A Burchill

Leeds Institute of Medical Research, St. James's University Hospital

Career Start Year 1986

Number of shared co-authors 0

Silvano Bosari

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Career Start Year 1986

Number of shared co-authors 2

Louis Gaboury

Institute for Research in Immunology and Cancer (IRIC), University of Montreal

Career Start Year 1986

Number of shared co-authors 0

Stefan Aebi

University of Bern

Career Start Year 1985

Number of shared co-authors 0

Seth M Steinberg

Center for Cancer Research, National Cancer Institute

Career Start Year 1984

Number of shared co-authors 4

Marco Mesiti

Universita degli Studi di Milano

Career Start Year 1984

Number of shared co-authors 0

Francisco X Real

Spanish National Cancer Research Centre-CNIO

Career Start Year 1983

Number of shared co-authors 6

John A Copland

Mayo Clinic Jacksonville

Career Start Year 1982

Number of shared co-authors 0

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 1

Adrian L Harris

University of Oxford

Career Start Year 1981

Number of shared co-authors 3

Jahn M Nesland

The Norwegian Radium Hospital, Oslo University Hospital

Career Start Year 1980

Number of shared co-authors 0

David M Thomas

Garvan Institute of Medical Research

Career Start Year 1980

Number of shared co-authors 4

Bernard T??tu

Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)

Career Start Year 1979

Number of shared co-authors 0

Robert H Shoemaker

National Cancer Institute

Career Start Year 1978

Number of shared co-authors 1

Peter J Selby

College of Agriculture and Life Sciences, Cornell University

Career Start Year 1977

Number of shared co-authors 6

Christopher C Benz

Buck Institute for Research on Aging

Career Start Year 1977

Number of shared co-authors 1

Wolfgang E Berdel

University Hospital Munster

Career Start Year 1976

Number of shared co-authors 2

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 5

David W Hedley

Princess Margaret Cancer Centre, University Health Network

Career Start Year 1975

Number of shared co-authors 2

William E Grizzle

University of Alabama at Birmingham

Career Start Year 1974

Number of shared co-authors 1

John N Weinstein

The University of Texas MD Anderson Cancer Center

Career Start Year 1968

Number of shared co-authors 7

William A Robinson

National Centre for Asbestos Related Diseases, University of Western Australia

Career Start Year 1967

Number of shared co-authors 0

Maria Mitzi Brentani

Sao Paulo University

Career Start Year 1964

Number of shared co-authors 0

row(s) 1 - 30 of 30

Emile E Voest

The Netherlands Cancer Institute

Co-authored papers 4

Mark Lawler

Queens University Belfast Belfast

Co-authored papers 4

Carlos Caldas

Cancer Research UK Cambridge Institute, University of Cambridge

Co-authored papers 3

Emmanuel Raffoux

Universite Paris Diderot

Co-authored papers 3

Lillian L Siu

Princess Margaret Cancer Centre, University Ave

Co-authored papers 3

Charles L Sawyers

Memorial Sloan Kettering Cancer Center

Co-authored papers 3

Joachim Sch??z

European Academy of Cancer Sciences

Co-authored papers 2

Gilles Thomas

Co-authored papers 2

Dominique Charron

Universite de Strasbourg

Co-authored papers 2

Angelika Eggert

Co-authored papers 2

Michael R Stratton

Wellcome Sanger Institute

Co-authored papers 2

Bartha Maria Knoppers

McGill University

Co-authored papers 2

Laurie Tonon

Cancer Research Center of Lyon, UMR INSERM 2, CNRS 5286

Co-authored papers 2

Anne-Sophie Sertier

Synergie Lyon Cancer Foundation

Co-authored papers 2

Marie-H??l??ne Schlageter

Universite de Paris, U1 INSERM

Co-authored papers 2

Hendrik Van Poppel

University Hospitals Leuven

Co-authored papers 2

Stephen J Chanock

National Cancer Institute, National Institutes of Health

Co-authored papers 2

Isabelle Ray-Coquard

University Claude Bernard Lyon I

Co-authored papers 2

N??ria Malats

Spanish National Cancer Research Centre

Co-authored papers 1

Melissa A Haendel

American Medical Informatics Association, Oregon Health and Science University, Oregon State University, University of Colorado Anschutz Medical Campus, University of North Carolina at Chapel Hill, University of Wisconsin-Madison

Co-authored papers 1

Claude Preudhomme

Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.

Co-authored papers 1

Kathryn N North

Murdoch Children's Research Institute

Co-authored papers 1

Gil Alterovitz

Brigham and Women's Hospital

Co-authored papers 1

William M Gallagher

All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin